7.2 Independent review
Page last updated: October 2016
An independent review of a submission and the PBAC decision is available if the PBAC has declined to recommend the listing of a medicine/vaccine on the PBS/NIP or, in certain circumstances, if the PBAC has not recommended extending the listing of a PBS/NIP item for an additional indication.
The PBAC states in its minutes if a submission is eligible for an independent review.
Details about the eligibility for, and the procedures undertaken in, the independent review are available on the PBS website.